(VCNX) |
| 0 (0%) 10-10 18:21 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.13 |
| Resistance 1: | 0.89 |
| Pivot price: | 0.60 |
| Support 1: | 0.50 |
| Support 2: | 0.42 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -18640000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 590.1 |
| Return on Equity (ttm) | -376.1 |
Company news
Tue, 26 Aug 2025
TR | OpenAI - 4o Maintains Vaccinex(VCNX.US) With Hold Rating, Cuts Target Price to $0.5 - 富途牛牛
Sun, 24 Aug 2025
TR | OpenAI - 4o Maintains Vaccinex(VCNX.US) With Hold Rating, Maintains Target Price $1 - 富途牛牛
Fri, 07 Mar 2025
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market - Yahoo Finance
Fri, 07 Mar 2025
Can Vaccinex Survive After Nasdaq Exit? Key Details on Company's Future Strategy - Stock Titan
Tue, 17 Dec 2024
Vaccinex, Inc. Faces Delisting from Nasdaq Due to Failure to Meet Continued Listing Standards - Nasdaq
Thu, 24 Oct 2024
Vaccinex Stock Spikes On Promising Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Stocktwits
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
